Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Oncodna has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners and 2 distinct art units, indicating that at least one art unit accommodates more than one examiner assignment.
GUSTILO, ESTELLA M is the busiest examiner, with 1 pending matter. Counsel should track examiner-specific issues while coordinating matters that share an art-unit context.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GUSTILO, ESTELLA M | 1 | 53.6% | +34.5% |
| RAYMONDA, MATTHEW HAROLD | 1 | 40.0% | +47.7% |
| PHAM, KHAI QUYNH TIEN | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691296 | RNA Vaccine Comprising an RNA Pool Generated From a Double-Stranded DNA Pool | GUSTILO, ESTELLA M | — |
| 18293951 | METHOD OF MUTATION DETECTION IN A LIQUID BIOPSY | PHAM, KHAI QUYNH TIEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691296 | RNA Vaccine Comprising an RNA Pool Generated From a Double-Stranded DNA Pool | GUSTILO, ESTELLA M | — |
| 18690453 | METHOD TO GENERATE A DOUBLE-STRANDED DNA POOL ENCODING NEOANTIGENS OF A TUMOR OF A PATIENT | RAYMONDA, MATTHEW HAROLD | — |
| Art Unit | Apps |
|---|---|
| 1684 | 2 |
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18691296 | RNA Vaccine Comprising an RNA Pool Generated From a Double-Stranded DNA Pool | GUSTILO, ESTELLA M | 1646 | §101§102§112DP | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18690453 | METHOD TO GENERATE A DOUBLE-STRANDED DNA POOL ENCODING NEOANTIGENS OF A TUMOR OF A PATIENT | RAYMONDA, MATTHEW HAROLD | 1684 | §102§112DP | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18293951 | METHOD OF MUTATION DETECTION IN A LIQUID BIOPSY | PHAM, KHAI QUYNH TIEN | 1684 | §101§102§103 | Non-Final OA | — | Pending | Jan 31, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOncodna has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Estella M Gustilo has the most, with 1 of Oncodna's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
